Unfractionated Heparin Drug Market

Unfractionated Heparin Market (Source -Bovine and Porcine; Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025

  • Rep Id : TMRGL32198
  • Published On : Feb 2018
  • No. of Pages : 142
  • Category : Pharmaceutical

1. Preface
      1.1. Report Scope and Market Segmentation
      1.2. Research Highlights

2. Assumptions and Research Methodology
      2.1. Assumptions
      2.2. Research Methodology
      2.3. Acronyms Used

3. Executive Summary

4. Market Overview
      4.1. Product Overview
      4.2. Drivers and Restraints Snapshot Analysis
      4.3. Drivers
             4.3.1. Rise in the incidence of coagulation and renal and heart diseases
             4.3.2. Inclination of slaughterhouse owners toward entering into the crude unfractionated heparin processing business
             4.3.3. Ban on imports from China to boost production in Europe
      4.4. Restraints
             4.4.1. Availability of alternative anticoagulants
             4.4.2. Enhanced quality control measures
             4.4.3. Patent expiry and increasing use of off-label products
      4.5. Opportunities
             4.5.1. Biosimilar-based heparin products
             4.5.2. Heparin diversification: alternative sources of unfractionated heparin
      4.6. Key Trends
      4.7. Opportunity Analysis
      4.8. Global Unfractionated Heparin Market Size (US$ Mn) Forecast

5. Global Unfractionated Heparin Market Analysis, by Source
      5.1. Key Findings
      5.2. Introduction
      5.3. Global Unfractionated Heparin Market Value Share Analysis, by Source
      5.4. Global Unfractionated Heparin Market Forecast, by Source
             5.4.1. Bovine 
             5.4.2. Porcine
      5.5. Global Unfractionated Heparin Market Analysis, by Source
      5.6. Global Unfractionated Heparin Market Attractiveness Analysis, by Source

6. Global Unfractionated Heparin Market Analysis, by Distribution Channel
      6.1. Key Findings
      6.2. Introduction
      6.3. Global Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      6.4. Global Unfractionated Heparin Market Forecast, by Distribution Channel
             6.4.1. Hospital Pharmacies
             6.4.2. Retail Pharmacies
             6.4.3. Online Pharmacies
      6.5. Global Unfractionated Heparin Market Analysis, by Distribution Channel
      6.6. Global Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel

7. Global Unfractionated Heparin Market Analysis, by Region
      7.1. Global Unfractionated Heparin Market Scenario, by Country
      7.2. Global Unfractionated Heparin Market Value Share Analysis, by Region
      7.3. Global Unfractionated Heparin Market Forecast, by Region
             7.3.1. North America
             7.3.2. Europe
             7.3.3. Asia Pacific
             7.3.4. Latin America
             7.3.5. Middle East and Africa
      7.4. Global Unfractionated Heparin Market Attractiveness Analysis, by Region

8. North America Unfractionated Heparin Market Analysis
      8.1. Key Findings
      8.2. North America Unfractionated Heparin Market Overview
      8.3. North America Unfractionated Heparin Market Value Share Analysis, by Source
      8.4. North America Unfractionated Heparin Market Forecast, by Source
      8.5. North America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      8.6. North America Unfractionated Heparin Market Forecast, by Distribution Channel
      8.7. North America Unfractionated Heparin Market Attractiveness Analysis 
      8.8. North America Unfractionated Heparin Market Value Share Analysis, by Country
             8.8.1. U.S.
             8.8.2. Canada

9. Europe Unfractionated Heparin Market Analysis
      9.1. Key Findings
      9.2. Europe Unfractionated Heparin Market Overview
      9.3. Europe Unfractionated Heparin Market Value Share Analysis, by Source
      9.4. Europe Unfractionated Heparin Market Forecast, by Source
      9.5. Europe Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      9.6. Europe Unfractionated Heparin Market Forecast, by Distribution Channel
      9.7. Europe Unfractionated Heparin Market Attractiveness Analysis 
      9.8.  Europe Unfractionated Heparin Market Value Share Analysis, by Country
      9.9. Europe Unfractionated Heparin Market Forecast, by Country
             9.9.1. Germany 
             9.9.2. U.K.
             9.9.3. France
             9.9.4. Italy
             9.9.5. Spain
             9.9.6. Rest of the Europe 

10. Asia Pacific Unfractionated Heparin Market Analysis
      10.1. Key Findings
      10.2. Asia Pacific Unfractionated Heparin Market Overview
      10.3. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Source
      10.4. Asia Pacific Unfractionated Heparin Market Forecast, by Source
      10.5. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      10.6. Asia Pacific Unfractionated Heparin Market Forecast, by Distribution Channel
      10.7. Asia Pacific Unfractionated Heparin Market Attractiveness Analysis 
      10.8. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Country
      10.9. Asia Pacific Unfractionated Heparin Market Forecast, by Country
             10.9.1. China
             10.9.2. India
             10.9.3. Japan
             10.9.4. Australia 
             10.9.5. Indonesia
             10.9.6. Malaysia
             10.9.7. Rest of Asia Pacific

11. Latin America Unfractionated Heparin Market Analysis
      11.1. Key Findings
      11.2. Latin America Unfractionated Heparin Market Overview
      11.3. Latin America Unfractionated Heparin Market Value Share Analysis, by Source
      11.4. Latin America Unfractionated Heparin Market Forecast, by Source
      11.5. Latin America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      11.6. Latin America Unfractionated Heparin Market Forecast, by Distribution Channel
      11.7. Latin America Unfractionated Heparin Market Attractiveness Analysis 
      11.8. Latin America Unfractionated Heparin Market Value Share Analysis, by Country
      11.9. Latin America Unfractionated Heparin Market Forecast, by Country
             11.9.1. Brazil
             11.9.2. Mexico 
             11.9.3. Rest of LATAM 

12.  Middle East & Africa Unfractionated Heparin Market Analysis
      12.1. Key Findings
      12.2. Middle East & Africa Unfractionated Heparin Market Overview
      12.3. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Source
      12.4. Middle East & Africa Unfractionated Heparin Market Forecast, by Source
      12.5. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
      12.6. Middle East & Africa Unfractionated Heparin Market Forecast, by Distribution Channel
      12.7. Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis 
      12.8. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Country
      12.9. Middle East & Africa Unfractionated Heparin Market Forecast, by Country
             12.9.1. GCC Countries
             12.9.2. South Africa
             12.9.3. Israel
             12.9.4. Rest of Middle East & Africa

13. Competition Landscape
      13.1. Market Share Analysis
      13.2. Competition Matrix
             13.2.1. Fresenius SE & Co. KGaA 
                       13.2.1.1. Company Details
                       13.2.1.2. Business Overview
                       13.2.1.3. Financial Overview
                       13.2.1.4. Strategic Overview
                       13.2.1.5. SWOT Analysis
             13.2.2. Pfizer, Inc. 
                       13.2.2.1. Company Details
                       13.2.2.2. Business Overview
                       13.2.2.3. Financial Overview
                       13.2.2.4. Strategic Overview
                       13.2.2.5. SWOT Analysis
             13.2.3. LEO Pharma A/S 
                       13.2.3.1. Company Details
                       13.2.3.2. Business Overview
                       13.2.3.3. Financial Overview
                       13.2.3.4. Strategic Overview
                       13.2.3.5. SWOT Analysis
             13.2.4. Baxter International Inc. 
                       13.2.4.1. Company Details
                       13.2.4.2. Business Overview
                       13.2.4.3. Financial Overview
                       13.2.4.4. Strategic Overview
                       13.2.4.5. SWOT Analysis
             13.2.5. B. Braun Melsungen AG 
                       13.2.5.1. Company Details
                       13.2.5.2. Business Overview
                       13.2.5.3. Financial Overview
                       13.2.5.4. Strategic Overview
                       13.2.5.5. SWOT Analysis
             13.2.6. Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceutical Co.)
                       13.2.6.1. Company Details
                       13.2.6.2. Business Overview
                       13.2.6.3. Financial Overview
                       13.2.6.4. Strategic Overview
                       13.2.6.5. SWOT Analysis
             13.2.7. Mylan Inc. 
                       13.2.7.1. Company Details
                       13.2.7.2. Business Overview
                       13.2.7.3. Financial Overview
                       13.2.7.4. Strategic Overview
                       13.2.7.5. SWOT Analysis
                       13.2.8. Other Prominent Players

List of Tables

Table 1: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 2: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 3: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 4: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 5: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 6: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 7: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 8: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 9: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 11: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 14: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 16: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 17: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 19: Fresenius SE & Co. KGaA Products Offering
Table 20: Pfizer, Inc. products offering
Table 21: Leo Pharma A/S products offering
Table 22: Baxter International Inc. Products Offering
Table 23: B.Braun Melsungen AG Products Offering
Table 24: Sagent Pharmaceuticals, Inc. Products Offering
Table 25: Mylan Inc. Products Offering

List of Figures

Figure 01: Global Unfractionated Heparin Market Share (US$ Mn), by Distribution Channel, 2016
Figure 02: Global Unfractionated Heparin Market Share (%), by Source, 2016
Figure 03: Revenue Share, 2016
Figure 04: Global Unfractionated Heparin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 05: Market Value Share, by Source (2016)
Figure 06: Market Value Share, by Distribution Channel (2016)
Figure 07: Market Value Share, by Region (2016) 
Figure 08: Global Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 09: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bovine, 2015–2025
Figure 10: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porcine, 2015–2025
Figure 11: Global Unfractionated Heparin Market Attractiveness, by Source
Figure 12: Global Unfractionated Heparin Market Value Share, by Distribution Channel, 2016 and 2025
Figure 13: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
Figure 14: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015–2025
Figure 15: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2015–2025
Figure 16: Global Unfractionated Heparin Market Attractiveness, by Distribution Channel
Figure 17: Global Unfractionated Heparin Market Value Share, by Region, 2016 and 2025
Figure 18: Global Unfractionated Heparin Market Attractiveness, by Region
Figure 19: North America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 20: North America Unfractionated Heparin Market Attractiveness Analysis, by Country, 2017–2025
Figure 21: North America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 22: North America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 23: North America Unfractionated Heparin Market Attractiveness Analysis, by Source, 2017–2025
Figure 24: North America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 25: North America Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
Figure 26: Europe Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 27: Europe Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 28: Europe Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 29: Europe Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 30: Europe Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 31: Europe Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 32: Europe Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 33: Asia Pacific Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 34: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 35: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 36: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 37: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 38: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 39: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 40: Latin America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 41: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 42: Latin America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 43: Latin America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 44: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 45: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 46: Latin America Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 47: Middle East & Africa Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 48: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Country
Figure 49: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 50: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 52: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 53: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
Figure 54: Fresenius SE & Co. KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 55: Fresenius SE & Co. KGaA R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 56: Fresenius SE & Co. KGaA Breakdown of Net Sales, By Region 2016
Figure 57: Fresenius SE & Co. KGaA Breakdown of Net Sales, by Segment, (overall company level), 2016
Figure 58: Pfizer, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 59: Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 60: Pfizer, Inc. Breakdown of Net Sales, By Region 2016
Figure 61: Pfizer, Inc. Breakdown of Net Sales, By Business Segments, 2017
Figure 62: LEO Pharma A/S Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 63: LEO Pharma A/S Breakdown of Net Sales, By Region, 2017
Figure 64: LEO Pharma A/S Breakdown of Net Sales, By Business Segments, 2017
Figure 65: Baxter International Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 66: Baxter International Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 67: Baxter International Inc. Breakdown of Net Sales, By Region 2016
Figure 68: Baxter International Inc. Breakdown of Net Sales, (Overall Company Level), 2016
Figure 69: B. Braun Melsungen AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 70: B. Braun Melsungen AG R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 71: B. Braun Melsungen AG Breakdown of Net Sales, By Region 2016
Figure 72: B. Braun Melsungen AG Breakdown of Net Sales, (Overall Company Level), 2016
Figure 73: Mylan Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Mylan Inc. R&D Intensity and Sales & Marketing Intensity (%) 2014–2016
Figure 75: Mylan Inc. Breakdown of Net Sales, By Region, 2016

.